Tara M. Tereso, Group Executive of IDEX Corporation's Health and Science Technologies segment, filed a statement of changes in beneficial ownership on September 18, 2026, reporting a disposition of common stock on September 16, 2026.
Stephen Michael Kelsey, Senior Advisor to the Chief Executive Officer at Revolution Medicines, Inc. (NASDAQ:RVMD), filed a Form 4 on September 18, 2026, disclosing the sale of common stock on September 16, 2026, pursuant to a pre-established Rule 10b5-1 trading plan.
Anthony Mancini, Chief Global Commercialization Officer of Revolution Medicines, Inc. (NASDAQ:RVMD), filed a Form 4 on September 18, 2026, disclosing the sale of common stock on September 16, 2026 pursuant to a pre-established Rule 10b5-1 trading plan.
Alan B. Sandler, Chief Development Officer of Revolution Medicines, Inc. (NASDAQ:RVMD), filed a Form 4 on September 18, 2026, reporting two sales of common stock on September 16, 2026, executed under a pre-established Rule 10b5-1 trading plan.
Michael Linford, President of Affirm Holdings, Inc., filed a Form 4 on September 18, 2026, disclosing the acquisition of 67,006 restricted stock units in the company's Class A Common Stock on September 16, 2026.
Libor Michalek, President and Director of Affirm Holdings, Inc. (NASDAQ:AFRM), filed a Form 4 on September 18, 2026, disclosing the acquisition of 67,006 Restricted Stock Units on September 16, 2026.
ICONIQ Strategic Partners II, L.P. and affiliated entities filed a Form 4 with the SEC on September 18, 2026, reporting in-kind distributions of Netskope Inc (NASDAQ:NTSK) Class A Common Stock made on September 16, 2026, for no consideration, to their respective limited partners.
Katherine Adkins, Chief Legal Officer of Affirm Holdings, Inc. (NASDAQ:AFRM), filed a Form 4 on September 18, 2026, disclosing the acquisition of 30,152 Restricted Stock Units on September 16, 2026.
A statement of changes in beneficial ownership filed on September 18, 2026, disclosed that Zoetis Inc. director Mark Stetter acquired phantom stock units on September 17, 2026, under the company's director deferred compensation plan.
William J.G. Griffith, a director and 10% owner of Netskope Inc, filed a Form 4 on September 18, 2026, reporting in-kind distributions of Class A Common Stock made on September 16, 2026 from two ICONIQ Strategic Partners funds to their limited partners.